Vaccinex, Inc. Preferred Stock Dividends, Income Statement Impact
Vaccinex, Inc. (VCNX) reported Preferred Stock Dividends, Income Statement Impact of $800.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2019-03-13
- Vaccinex, Inc. preferred stock dividends, income statement impact for the quarter ending 2018-06-30 was $800.00K, a 0.00% change year-over-year.
- Vaccinex, Inc. preferred stock dividends, income statement impact for the quarter ending 2017-12-31 was $810.00K.
- Vaccinex, Inc. preferred stock dividends, income statement impact for the quarter ending 2017-09-30 was $809.00K.
- Vaccinex, Inc. preferred stock dividends, income statement impact for the quarter ending 2017-06-30 was $800.00K.
- Vaccinex, Inc. preferred stock dividends, income statement impact for fiscal 2017 was $3.21M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2018-06-30 | $800.00K 10-Q · filed 2018-08-14 | $1.59M 10-Q · filed 2018-08-14 | ||
| 2017-12-31 | $810.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.62M derived: sum of 2 quarters · filed 2019-03-13 | $2.42M derived: sum of 3 quarters · filed 2019-03-13 | $3.21M 10-K · filed 2019-03-13 |
| 2017-09-30 | $809.00K 10-Q · filed 2018-11-13 | $1.61M derived: sum of 2 quarters · filed 2018-11-13 | $2.40M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $800.00K 10-Q · filed 2018-08-14 | $1.59M 10-Q · filed 2018-08-14 |